GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes – Endocrinology Advisor
GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes Endocrinology Advisor Source link
Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis – TCTMD
Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis TCTMD Source link
Talking Sex: CVD Patients Want to Hear More From Clinicians – TCTMD
Talking Sex: CVD Patients Want to Hear More From Clinicians TCTMD Source link
U-shaped association between HbA1c and all-cause mortality in CVD patients with diabetes | Scientific Reports – Nature.com
U-shaped association between HbA1c and all-cause mortality in CVD patients with diabetes | Scientific Reports Nature.com Source link
EGDRC Seminar: Diabetes Treatments for CVD Prevention – Creative Loafing
EGDRC Seminar: Diabetes Treatments for CVD Prevention Creative Loafing Source link
Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD – MD Magazine
Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD MD Magazine Source link
Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes – Nature.com
Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes Nature.com Source link
Does Metformin Therapy Impact CVD in T2D? It's Complicated – Medscape
Does Metformin Therapy Impact CVD in T2D? It’s Complicated Medscape Source link
Intensive therapy may blunt higher CVD risk for younger women with hypertension, diabetes
Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try again later. If you continue to have…